Bal Pharma Price to Sales Ratio (P/S)

Bal Pharma Ltd Price to Sales Ratio

The Bal Pharma Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Bal Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Bal Pharma Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Bal Pharma Ltd (NSE: BALPHARMA, BSE: 524824) is currently trading at ₹108.16, with a market capitalization of ₹174.02Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Bal Pharma Ltd Price to Sales Ratio is essential for fundamental analysis.

Bal Pharma Ltd Price to Sales Ratio Current Value

The current Bal Pharma Ltd Price to Sales Ratio stands at 0.

The Bal Pharma Ltd Price to Sales Ratio remains stable, indicating consistent financial performance.

Bal Pharma Ltd Price to Sales Ratio Historical Trend

The Bal Pharma Ltd Price to Sales Ratio has shown the following historical trend:

The decline in Bal Pharma Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.

What Bal Pharma Ltd Price to Sales Ratio Indicates for Investors

The Bal Pharma Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Bal Pharma Ltd Price to Sales Ratio Analysis Summary

The Bal Pharma Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Bal Pharma Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Bal Pharma Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.